P. Biswal and B. Mallick,"miR-185–5p rewires cisplatin resistance by restoring miR-203a-3p expression via downregulation of SOX9", DNA Repair, vol.142, no.103750, pp.1-15, Elsevier, October 2024, 10.1016/j.dnarep.2024.103750       Article

R. Nayak and B. Mallick,"BMS345541 is predicted as a repurposed drug for the treatment of TMZ-resistant Glioblastoma using target gene expression and virtual drug screening", Cancer Genetics, Elsevier, November 2024, 10.1016/j.cancergen.2024.08.082       Article

T. Chattopadhyay and B. Mallick,"FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma", Life Sciences, vol.329, no.121954, pp.1-19, Elsevier, July 2023, 10.1016/j.lfs.2023.121954       Article

P. Gupta, G. Das, T. Chattopadhyay, Z. Ghosh, and B. Mallick,"TarpiD, a database of putative and validated targets of piRNAs", Molecular Omics, vol.19, pp.706-713, RSC, November 2023, 10.1039/D3MO00098B       Article

R. Nayak, T. Chattopadhyay, P. Gupta, and B. Mallick,"Integrative analysis of small non-coding RNAs predicts a piRNA/miRNA-CCND1/BRAF/HRH1/ATXN3 regulatory circuit that drives oncogenesis in glioblastoma", Molecular Omics, vol.19, pp.252-261, RSC, March 2023, 10.1039/D2MO00245K       Article

T. Chattopadhyay and B. Mallick,"FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma", Life Sciences, vol.329, no.121954, pp.1-19, Elsevier, September 2023, 10.1016/j.lfs.2023.121954       Article

R. Nayak and B. Mallick,"LncRNA-associated competing endogenous RNA network analysis uncovered key lncRNAs involved in temozolomide resistance and tumor recurrence of glioblastoma", Journal of Molecular Recognition, vol.36, no.12, pp.1-13, Wiley, December 2023, 10.1002/jmr.3060       Article

T. Chattopadhyay, P. Gupta, R. Nayak, and B. Mallick,"Genome-wide profiling of dysregulated piRNAs and their target genes implicated in oncogenicity of tongue squamous cell carcinoma", Gene, vol.849, no.146919, pp.1-13, Elsevier, January 2023, 10.1016/j.gene.2022.146919       Article

N. Jain, B. Das, and B. Mallick,"miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux", DNA Repair, vol.109, no.103259, pp.1-9, Elsevier, January 2022, 10.1016/j.dnarep.2021.103259       Article

B. Das, N. Jain, and B. Mallick,"Ribonucleotide reductase subunit M2 is a potential prognostic marker and therapeutic target for soft tissue sarcoma", Gene, vol.808, no.145988, pp.1-14, Elsevier, January 2022, 10.1016/j.gene.2021.145988       Article